Use of phytoecdysones in the preparation of a composition for acting on metabolic syndrome
A technology of phytoecdysone and ecdysone, which is applied in the direction of medical preparations containing active ingredients, drug combinations, metabolic diseases, etc., and can solve problems such as toxicity and insufficient efficacy of abdominal obesity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0028]In the present invention, it is proposed to provide concentrated doses of pure phytoecdysone, or through concentrated plant extracts of phytoecdysone, in order to improve the health of overweight people, or to avoid overweight caused by the accumulation of abdominal or visceral fat. It is one of the main clinical markers of metabolic syndrome and a risk factor for the onset of cardiovascular disease and type 2 diabetes.
[0029] The limiting dose of phytoecdysone contained in the composition according to the invention, allowing to obtain a positive therapeutic effect on fat mass, in humans is 0.3 to 0.5 mg / kg, ie an average of 20 to 30 mg per day. This estimate is based on the detection of physiological responses in mice (C57Bl6 line mice) at a dose of 5 mg / kg. Considering that the mean half-life of phytoecdysone is longer in humans than in mice, this dose has been adjusted for pharmacological correspondence (Koolman, 1989).
[0030] According to the present invention, ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com